# OMass Therapeutics funding: rounds and investors > OMass Therapeutics has raised $442M across 6 rounds since 2021. Investors include Google Ventures, Oxford Science Enterprises and Northpond Ventures. Source: https://millionrounds.com/company/omass-therapeutics (Millionrounds; every figure on the page links to its filing or article) United Kingdom · [Series C startup](https://millionrounds.com/companies) # Who invested in *OMass Therapeutics* 6 rounds we have observed, with the 14 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Biotech Pharma Raised this month Funding summary Updated 26 Oct 2026 **$442M** raised across 6 rounds since 2021, from 7 sources **$12M** Series A **$10M** Round **$13M** Series B **$44M** Series B **$53M** Series C **$310M** Series C - **Latest round:** Series C, $310M Oct 2026 - **Led by:** Novo Holdings and Forbion Capital Partners and 1 more - **Step-up i:** 5.8× - **Investors:** 14 (3 led) See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2022 2023 2024 2025 2026 **$12M** Series A **$10M** Round **$13M** Series B **$44M** Series B **$53M** Series C **$310M** Series C - **First round:** Series A, $12M - **Biggest round:** $310M - **Usual gap between rounds:** 15 months ## The rounds - **Oct 2026** Series C **$310M** *10 new* *3 returning* [Novo Holdings](https://millionrounds.com/fund/novo-ventures) Lead [Forbion Capital Partners](https://millionrounds.com/fund/forbion-capital-partners) Lead [Bain Capital Life Sciences](https://millionrounds.com/fund/bain-capital-life-sciences) Lead [Google Ventures](https://millionrounds.com/fund/gv) [Janus Henderson Investors](https://millionrounds.com/fund/janus-henderson-investors) [Oxford Science Enterprises](https://millionrounds.com/fund/oxford-science-enterprises) [British Business Bank](https://millionrounds.com/fund/national-security-strategic-investment-fund) [SV Health Investors](https://millionrounds.com/fund/sv-health-investors) [Northpond Ventures](https://millionrounds.com/fund/northpond-ventures) [Sanofi Ventures](https://millionrounds.com/fund/sanofi-ventures) [Syncona](https://millionrounds.com/fund/syncona-limited) [University of Oxford](https://millionrounds.com/fund/university-of-oxford) [Jefferson Life Sciences](https://millionrounds.com/fund/jefferson-life-sciences) Reported by Jefferson Life Sciences and 1 other - **Sept 2026** Series C **$53M** No investor was named in the report. Shares issued, filed with Companies House (SH01); no report of this raise yet - **Jul 2024** Series B **$44M** No investor was named in the report. Shares issued, filed with Companies House (SH01); no report of this raise yet - **May 2023** Series B **$13M** *4 new* [Google Ventures](https://millionrounds.com/fund/gv) [Oxford Science Enterprises](https://millionrounds.com/fund/oxford-science-enterprises) [Sanofi](https://millionrounds.com/fund/sanofi) [Northpond Ventures](https://millionrounds.com/fund/northpond-ventures) Source recorded - **Mar 2022** Round **$10M** No investor was named in the report. Shares issued, filed with Companies House (SH01); no report of this raise yet - **Aug 2021** Series A **$12M** No investor was named in the report. Shares issued, filed with Companies House (SH01); no report of this raise yet ## Funding filed with regulators OMass Therapeutics filed 5 raises, $127M in all. Filings say how much was sold and to how many investors; they never name the investors. - Sept 2026 **$53M** UK share allotment - Jul 2024 **$44M** UK share allotment - Apr 2023 **$7.5M** UK share allotment - Mar 2022 **$10M** UK share allotment - Aug 2021 **$12M** UK share allotment ## Founders and team From OMass Therapeutics's own website: 3 founders, 14 on the team. **Jonathan Hopper** Vice President, Platforms and Founder **Idlir Liko** Founder **Working Here** Founder - **Rosamond Deegan** Chief Executive Officer - **Jon Roffey** Senior Vice President of Discovery and Non-Clinical - **Steve Griffen** Vice President, Clinical Development - **Melissa Faris** Chief Business Officer - **Professor Steven Charlton** Chief Scientific Officer - **Carol Schafer** Non-executive Director - **Chris Ashton** Non-executive Director - **Diana Bernstein** Non-executive Director - **Edward Hodgkin** Non-executive Director - **Jonathan Montagu** Chairman - **Laia Crespo** Non-executive Director - **Nathalie Franchimont** Non-executive Director - **Pierre Joffrin** Non-executive Director - **Scott Biller** Non-executive Director Advisers *Professor Dame Carol Robinson* ## Who was in which round The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led. **Series A** 2021 **Round** 2022 **Series B** 2023 **Series B** 2024 **Series C** 2026 **Series C** 2026 [Google Ventures](https://millionrounds.com/fund/gv) [Oxford Science Enterprises](https://millionrounds.com/fund/oxford-science-enterprises) [Northpond Ventures](https://millionrounds.com/fund/northpond-ventures) [Novo Holdings](https://millionrounds.com/fund/novo-ventures) L [Forbion Capital Partners](https://millionrounds.com/fund/forbion-capital-partners) L [Bain Capital Life Sciences](https://millionrounds.com/fund/bain-capital-life-sciences) L [Janus Henderson Investors](https://millionrounds.com/fund/janus-henderson-investors) [British Business Bank](https://millionrounds.com/fund/national-security-strategic-investment-fund) [Sanofi](https://millionrounds.com/fund/sanofi) [SV Health Investors](https://millionrounds.com/fund/sv-health-investors) ## Everyone who backed them [Google Ventures](https://millionrounds.com/fund/gv) Corporate VC **2** rounds [Oxford Science Enterprises](https://millionrounds.com/fund/oxford-science-enterprises) VC firm **2** rounds [Northpond Ventures](https://millionrounds.com/fund/northpond-ventures) Private equity **2** rounds [Novo Holdings](https://millionrounds.com/fund/novo-ventures) VC firm **1** round, led 1 [Forbion Capital Partners](https://millionrounds.com/fund/forbion-capital-partners) Private equity **1** round, led 1 [Bain Capital Life Sciences](https://millionrounds.com/fund/bain-capital-life-sciences) Private equity **1** round, led 1 [Janus Henderson Investors](https://millionrounds.com/fund/janus-henderson-investors) Private equity **1** round [British Business Bank](https://millionrounds.com/fund/national-security-strategic-investment-fund) Corporate VC **1** round [Sanofi](https://millionrounds.com/fund/sanofi) Investment firm **1** round [SV Health Investors](https://millionrounds.com/fund/sv-health-investors) VC firm **1** round [Sanofi Ventures](https://millionrounds.com/fund/sanofi-ventures) Corporate VC **1** round [Syncona](https://millionrounds.com/fund/syncona-limited) VC firm **1** round [University of Oxford](https://millionrounds.com/fund/university-of-oxford) Investment firm **1** round [Jefferson Life Sciences](https://millionrounds.com/fund/jefferson-life-sciences) Family office **1** round Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=omass-therapeutics). ## Quick answers about OMass Therapeutics ### Who invested in OMass Therapeutics? OMass Therapeutics's investors include Google Ventures, Oxford Science Enterprises, Northpond Ventures, Novo Holdings and Forbion Capital Partners, and 9 more on record. Novo Holdings led its latest round. ### How much has OMass Therapeutics raised? OMass Therapeutics has raised $442M across 6 rounds since 2021. ### When did OMass Therapeutics last raise? OMass Therapeutics's most recent round was a Series C of $310M in Oct 2026, led by Novo Holdings. ### What was OMass Therapeutics's biggest round? Its most recent round, $310M in Oct 2026, is also its largest on record. ### Who backed OMass Therapeutics first? OMass Therapeutics's first round on record, in May 2023, was backed by Google Ventures, Oxford Science Enterprises and Sanofi and 1 others. ### What stage is OMass Therapeutics at? OMass Therapeutics's latest named round is a Series C, in Oct 2026. ### Where is OMass Therapeutics based? OMass Therapeutics is based in the United Kingdom. ### Who led OMass Therapeutics's rounds? Novo Holdings led the Series C in 2026. ## Companies like OMass Therapeutics In the same sector, and raised in the last eighteen months. [**HydRegen** $12M · Oct 2026](https://millionrounds.com/company/hydregen)[**CMR Surgical** $1.1B · Oct 2026](https://millionrounds.com/company/cmr-surgical)[**Living Optics** $61M · Oct 2026](https://millionrounds.com/company/living-optics)[**Bactobio** $18M · Oct 2026](https://millionrounds.com/company/bactobio)[**Aptadir Therapeutics** $47M · Sept 2026](https://millionrounds.com/company/aptadir-therapeutics)[**RHYTHM AI** $23M · Sept 2026](https://millionrounds.com/company/rhythm-ai) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app